Effectiveness of crizotinib in a patient with ALK IHC-positive/FISH-negative metastatic lung adenocarcinoma

A. Rosoux; P. Pauwels; F. Duplaquet; N. D'Haene; B. Weynand; M. Delos; R. Menon; L. C. Heukamp; E. Thunnissen; S. Ocak

doi:10.1016/j.lungcan.2016.06.001

Effectiveness of crizotinib in a patient with ALK IHC-positive/FISH-negative metastatic lung adenocarcinoma

A. Rosoux, P. Pauwels, F. Duplaquet, N. D'Haene, B. Weynand, M. Delos, R. Menon, L. C. Heukamp, E. Thunnissen, S. Ocak

Pathology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	118-121
Journal	Lung Cancer
Volume	98
DOIs	https://doi.org/10.1016/j.lungcan.2016.06.001
Publication status	Published - Aug 2016

Access to Document

10.1016/j.lungcan.2016.06.001

Cite this

@article{14ddb827f2064e89832b0dd09a9e5784,

title = "Effectiveness of crizotinib in a patient with ALK IHC-positive/FISH-negative metastatic lung adenocarcinoma",

keywords = "ALK, Crizotinib, Fluorescent in situ hybridization, Immunohistochemistry, Non-small-cell lung cancer",

author = "A. Rosoux and P. Pauwels and F. Duplaquet and N. D'Haene and B. Weynand and M. Delos and R. Menon and Heukamp, {L. C.} and E. Thunnissen and S. Ocak",

year = "2016",

month = aug,

doi = "10.1016/j.lungcan.2016.06.001",

language = "English",

volume = "98",

pages = "118--121",

journal = "Lung Cancer",

issn = "0169-5002",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Effectiveness of crizotinib in a patient with ALK IHC-positive/FISH-negative metastatic lung adenocarcinoma

AU - Rosoux, A.

AU - Pauwels, P.

AU - Duplaquet, F.

AU - D'Haene, N.

AU - Weynand, B.

AU - Delos, M.

AU - Menon, R.

AU - Heukamp, L. C.

AU - Thunnissen, E.

AU - Ocak, S.

PY - 2016/8

Y1 - 2016/8

KW - ALK

KW - Crizotinib

KW - Fluorescent in situ hybridization

KW - Immunohistochemistry

KW - Non-small-cell lung cancer

U2 - 10.1016/j.lungcan.2016.06.001

DO - 10.1016/j.lungcan.2016.06.001

M3 - Article

C2 - 27393517

VL - 98

SP - 118

EP - 121

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

ER -